CJC 1295 with DAC 2mg

CJC-1295 with DAC is a modified Growth Hormone-Releasing Hormone (GHRH) designed to stimulate the pituitary gland to produce natural growth hormone. The Drug Affinity Complex (DAC) binds to serum albumin, giving the peptide a long half-life of 6 to 8 days, which allows for significantly fewer injections.How DAC Changes the PeptideExtended Half-Life: Without DAC, CJC-1295 typically has a short duration of action requiring more frequent administration. When DAC is attached, it binds to serum albumin and circulates in the bloodstream for up to a week, providing a prolonged release of growth hormone.Continuous Release: The DAC version elevates growth hormone levels consistently over several days rather than strictly mimicking the body's natural, sharp "pulse" cycles.Administration: Because of the prolonged presence in the body, the DAC version is generally administered less frequently, typically once or twice a week.Common ApplicationsIn research and wellness contexts, CJC-1295 is studied for its potential to affect body composition and cellular repair. Reported observations include:Fat Loss: Potential to aid in lipolysis (the breakdown of fats).Muscle Recovery: Potential for increased lean mass and faster recovery times after exercise.Sleep Quality: Potential for deeper and more restorative sleep patterns.